Recent review articles about cervical cancer (InTextoResearch)

InTextoResearch, scientific information agency


InTextoResearch informs on the most recent review articles on cervical
cancer:



Impact of the human papilloma vaccine on cervical cancer.
Chan JK, Berek JS.
J Clin Oncol. 2007 Jul 10;25(20):2975-82.

Management of metastatic cervical cancer: review of the literature.
Long HJ 3rd.
J Clin Oncol. 2007 Jul 10;25(20):2966-74.

Multimodality therapy for locally advanced cervical carcinoma: state
of the art and future directions.
Monk BJ, Tewari KS, Koh WJ.
J Clin Oncol. 2007 Jul 10;25(20):2952-65.

Cervical cancer screening following the implementation of prophylactic
human papillomavirus vaccination.
Franco EL, Ferenczy A.
Future Oncol. 2007 Jun;3(3):319-27.

Surgery insight: radical vaginal trachelectomy as a method of
fertility preservation for cervical cancer.
Beiner ME, Covens A.
Nat Clin Pract Oncol. 2007 Jun;4(6):353-61.

Cervical cancer screening in the 21st century: is it time to retire
the PAP smear?
Wright TC Jr.
Clin Obstet Gynecol. 2007 Jun;50(2):313-23.

Primary cervical choriocarcinoma: report of four cases and literature
review.
Fu Y, Lu W, Zhou C, Xie X.
Int J Gynecol Cancer. 2007 May-Jun;17(3):715-9.

Clinical trials in gynecological cancer.
Trimble EL, Davis J, Disaia P, Fujiwara K, Gaffney D, Kristensen G,
Ledermann J, Pfisterer J, Quinn M, Reed N, Schoenfeldt M, Thigpen JT;
Gynecologic Cancer Intergroup.
Int J Gynecol Cancer. 2007 May-Jun;17(3):547-56.

Integration of human papillomavirus vaccination, cytology, and human
papillomavirus testing.
Schiffman M.
Cancer. 2007 Jun 25;111(3):145-53.

"Occult" neuroendocrine component and rare metastatic pattern in
cervical cancer: report of a case and brief review of the literature.
Rhiem K, Possover M, Gossmann A, Drebber K, Mallmann P, Ulrich U.
Eur J Gynaecol Oncol. 2007;28(2):139-41.

The development and future of oligonucleotide-based therapies for
cervical cancer.
Gu W, Putral LN, Irving A, McMillan NA.
Curr Opin Mol Ther. 2007 Apr;9(2):126-31.

Immune concept of human papillomaviruses and related antigens in local
cancer milieu of human cervical neoplasia.
Sheu BC, Chang WC, Lin HH, Chow SN, Huang SC.
J Obstet Gynaecol Res. 2007 Apr;33(2):103-13.

Translational mini-review series on vaccines: Monitoring of human
papillomavirus vaccination.
Dillner J, Arbyn M, Dillner L.
Clin Exp Immunol. 2007 May;148(2):199-207.

Human papillomavirus vaccine: the beginning of the end for cervical
cancer.
Bornstein J.
Isr Med Assoc J. 2007 Mar;9(3):156-8.

Papillary squamotransitional cell carcinoma of the uterine cervix:
report of three cases and review of the literature.
Kokka F, Verma M, Singh N, Faruqi A, Yoon J, Reynolds K.
Pathology. 2006 Dec;38(6):584-6.

Advances in primary and secondary interventions for cervical cancer:
human papillomavirus prophylactic vaccines and testing.
Wheeler CM.
Nat Clin Pract Oncol. 2007 Apr;4(4):224-35.

Cost-effectiveness analyses of human papillomavirus vaccination.
Newall AT, Beutels P, Wood JG, Edmunds WJ, MacIntyre CR.
Lancet Infect Dis. 2007 Apr;7(4):289-96.

Molecular markers of miscellaneous primary and metastatic tumors of
the uterine cervix.
Chauhan SC, Kumar D, Bell MC, Koch MD, Verma M.
Eur J Gynaecol Oncol. 2007;28(1):5-14.

Human papillomavirus vaccine: progress and the future.
Dinh TA, Benoit MF.
Expert Opin Biol Ther. 2007 Apr;7(4):479-85.

Immunohistochemistry as a diagnostic aid in cervical pathology.
McCluggage WG.
Pathology. 2007 Feb;39(1):97-111.

Molecular targets in gynaecological cancers.
Cheung AN.
Pathology. 2007 Feb;39(1):26-45.




(InTextoResearch contact: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@xxxxxxxx)

.